These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 24079980

  • 1. New aminocoumarin antibiotics as gyrase inhibitors.
    Heide L.
    Int J Med Microbiol; 2014 Jan; 304(1):31-6. PubMed ID: 24079980
    [Abstract] [Full Text] [Related]

  • 2. Opposing effects of aminocoumarins and fluoroquinolones on the SOS response and adaptability in Staphylococcus aureus.
    Schröder W, Goerke C, Wolz C.
    J Antimicrob Chemother; 2013 Mar; 68(3):529-38. PubMed ID: 23169893
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of DNA gyrase and DNA topoisomerase IV of Staphylococcus aureus and Escherichia coli by aminocoumarin antibiotics.
    Alt S, Mitchenall LA, Maxwell A, Heide L.
    J Antimicrob Chemother; 2011 Sep; 66(9):2061-9. PubMed ID: 21693461
    [Abstract] [Full Text] [Related]

  • 4. Structure-activity relationships of aminocoumarin-type gyrase and topoisomerase IV inhibitors obtained by combinatorial biosynthesis.
    Flatman RH, Eustaquio A, Li SM, Heide L, Maxwell A.
    Antimicrob Agents Chemother; 2006 Apr; 50(4):1136-42. PubMed ID: 16569821
    [Abstract] [Full Text] [Related]

  • 5. Biological activities of novel gyrase inhibitors of the aminocoumarin class.
    Anderle C, Stieger M, Burrell M, Reinelt S, Maxwell A, Page M, Heide L.
    Antimicrob Agents Chemother; 2008 Jun; 52(6):1982-90. PubMed ID: 18347114
    [Abstract] [Full Text] [Related]

  • 6. New aminocoumarin antibiotics from genetically engineered Streptomyces strains.
    Li SM, Heide L.
    Curr Med Chem; 2005 Jun; 12(4):419-27. PubMed ID: 15720250
    [Abstract] [Full Text] [Related]

  • 7. Resistance genes of aminocoumarin producers: two type II topoisomerase genes confer resistance against coumermycin A1 and clorobiocin.
    Schmutz E, Mühlenweg A, Li SM, Heide L.
    Antimicrob Agents Chemother; 2003 Mar; 47(3):869-77. PubMed ID: 12604514
    [Abstract] [Full Text] [Related]

  • 8. Simocyclinone D8, an inhibitor of DNA gyrase with a novel mode of action.
    Flatman RH, Howells AJ, Heide L, Fiedler HP, Maxwell A.
    Antimicrob Agents Chemother; 2005 Mar; 49(3):1093-100. PubMed ID: 15728908
    [Abstract] [Full Text] [Related]

  • 9. 4-Quinolone interactions with gyrase subunit B inhibitors.
    Lewin CS, Howard BM, Smith JT.
    J Med Microbiol; 1991 Dec; 35(6):358-62. PubMed ID: 1661337
    [Abstract] [Full Text] [Related]

  • 10. Aminocoumarins mutasynthesis, chemoenzymatic synthesis, and metabolic engineering.
    Heide L.
    Methods Enzymol; 2009 Dec; 459():437-55. PubMed ID: 19362650
    [Abstract] [Full Text] [Related]

  • 11. Altering gene expression by aminocoumarins: the role of DNA supercoiling in Staphylococcus aureus.
    Schröder W, Bernhardt J, Marincola G, Klein-Hitpass L, Herbig A, Krupp G, Nieselt K, Wolz C.
    BMC Genomics; 2014 Apr 16; 15():291. PubMed ID: 24734910
    [Abstract] [Full Text] [Related]

  • 12. The biosynthetic gene clusters of aminocoumarin antibiotics.
    Li SM, Heide L.
    Planta Med; 2006 Oct 16; 72(12):1093-9. PubMed ID: 16868863
    [Abstract] [Full Text] [Related]

  • 13. GyrB mutations in Staphylococcus aureus strains resistant to cyclothialidine, coumermycin, and novobiocin.
    Stieger M, Angehrn P, Wohlgensinger B, Gmünder H.
    Antimicrob Agents Chemother; 1996 Apr 16; 40(4):1060-2. PubMed ID: 8849232
    [Abstract] [Full Text] [Related]

  • 14. Aminocoumarins inhibit osteoclast differentiation and bone resorption via downregulation of nuclear factor of activated T cells c1.
    Zheng T, Noh AL, Park H, Yim M.
    Biochem Pharmacol; 2013 Feb 01; 85(3):417-25. PubMed ID: 23123663
    [Abstract] [Full Text] [Related]

  • 15. Characterization of the aminocoumarin ligase SimL from the simocyclinone pathway and tandem incubation with NovM,P,N from the novobiocin pathway.
    Pacholec M, Freel Meyers CL, Oberthür M, Kahne D, Walsh CT.
    Biochemistry; 2005 Mar 29; 44(12):4949-56. PubMed ID: 15779922
    [Abstract] [Full Text] [Related]

  • 16. Curing of plasmid pE194 with novobiocin and coumermycin A1 in Bacillus subtilis and Staphylococcus aureus.
    Gadó I, Tóth I, Szvoboda G.
    Zentralbl Bakteriol Mikrobiol Hyg A; 1987 Jun 29; 265(1-2):136-45. PubMed ID: 2823505
    [Abstract] [Full Text] [Related]

  • 17. Mode of action of closthioamide: the first member of the polythioamide class of bacterial DNA gyrase inhibitors.
    Chiriac AI, Kloss F, Krämer J, Vuong C, Hertweck C, Sahl HG.
    J Antimicrob Chemother; 2015 Sep 29; 70(9):2576-88. PubMed ID: 26174721
    [Abstract] [Full Text] [Related]

  • 18. In vitro and in vivo production of new aminocoumarins by a combined biochemical, genetic, and synthetic approach.
    Galm U, Dessoy MA, Schmidt J, Wessjohann LA, Heide L.
    Chem Biol; 2004 Feb 29; 11(2):173-83. PubMed ID: 15123279
    [Abstract] [Full Text] [Related]

  • 19. Discovery of kibdelomycin, a potent new class of bacterial type II topoisomerase inhibitor by chemical-genetic profiling in Staphylococcus aureus.
    Phillips JW, Goetz MA, Smith SK, Zink DL, Polishook J, Onishi R, Salowe S, Wiltsie J, Allocco J, Sigmund J, Dorso K, Lee S, Skwish S, de la Cruz M, Martín J, Vicente F, Genilloud O, Lu J, Painter RE, Young K, Overbye K, Donald RG, Singh SB.
    Chem Biol; 2011 Aug 26; 18(8):955-65. PubMed ID: 21867911
    [Abstract] [Full Text] [Related]

  • 20. Mass spectrometric pathway monitoring of secondary metabolites: systematic analysis of culture extracts of Streptomyces species.
    Kammerer B, Kahlich R, Laufer S, Li SM, Heide L, Gleiter CH.
    Anal Biochem; 2004 Dec 01; 335(1):17-29. PubMed ID: 15519567
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.